RxDoctor Payments Data

Emily Clawson

Psychiatric/Mental Health · Marshalltown, IANPI 1891422606

Payments from drug & device makers

$1,244in general payments, 2019–2025

Across 74 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$225
  • Alkermes, Inc.$167
  • Otsuka America Pharmaceutical, Inc.$125
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$99
  • AbbVie$88
  • Axsome Therapeutics, Inc.$82
  • plus $459 from 11 others

What the payments were for

  • Food & beverage$1,244100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,244 in reported general payments places this provider in the 60th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$17,797
Medicare patients
38
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AristadaAripiprazole Lauroxil14$45,437
AuvelityDextromethorphan Hbr/Bupropion34$39,187
SpravatoEsketamine Hcl22$33,685
VraylarCariprazine Hcl20$28,545
RexultiBrexpiprazole12$18,620
SecuadoAsenapine11$16,152
Chlorpromazine Hcl15$11,170
TrintellixVortioxetine Hydrobromide22$7,474
QuviviqDaridorexant Hcl13$6,985
VyvanseLisdexamfetamine Dimesylate11$4,258
DayvigoLemborexant11$3,855
BelsomraSuvorexant11$2,572
Buspirone Hcl132$2,560
Bupropion XlBupropion Hcl112$2,448
Lurasidone Hcl29$1,985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada$167$45,43714 claims
Axsome Therapeutics, Inc.Auvelity$82$39,18734 claims
Johnson & JohnsonSpravato$225$33,68522 claims
AbbVieVraylar$88$28,54520 claims
Otsuka America Pharmaceutical, Inc.Rexulti$125$18,62012 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$37$11,73333 claims
Idorsia Pharmaceuticals US IncQuviviq$18$6,98513 claims
Almatica Pharma LLCSertraline Hcl$51$53161 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Marshalltown

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →